NCT05555329View on ClinicalTrials.gov

Alternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative Study

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

February 14, 2024

Study Completion Date

February 14, 2024

Conditions
Multiple Myeloma in RelapseMultiple MyelomaMultiple Myeloma, Refractory
Interventions
DRUG

Pomalidomide 4 mg every day in cycle 1

Pomalidomide 4 mg every day, on days 1-21 in a cycle of 28 days

DRUG

Pomalidomide 4 mg every other day in cycle 2

Pomalidomide 4 mg every other day, on days 1-21 in a cycle of 28 days

DRUG

Pomalidomide 2 mg every day in cycle 2

Pomalidomide 2 mg every day, on days 1-28 in a cycle of 28 days

DRUG

Pomalidomide 2 mg every day in cycle 3

Pomalidomide 2 mg every day, on days 1-28 in a cycle of 28 days

DRUG

Pomalidomide 4 mg every other day in cycle 3

Pomalidomide 4 mg every other day, on days 1-21 in a cycle of 28 days

Trial Locations (1)

Unknown

VUMedicalCenter, Amsterdam

All Listed Sponsors
lead

Amsterdam UMC, location VUmc

OTHER